[1]
Zhu, J.; Xu, Y.; Liu, S.; Qiao, L.; Sun, J.; Zhao, Q. 2020, MicroRNAs associated with colon cancer:New potential prognostic markers and targets for
therapy. Front. Bioeng. Biotechnol., 2020.
[http://dx.doi.org//10.3389/fbioe.2020.00176]
[http://dx.doi.org//10.3389/fbioe.2020.00176]
[2]
Feng, Y.; Zhang, Y.; Zhou, D.; Chen, G.; Li, N. 2019 MicroRNAs, intestinal inflammatory and tumor. Bioorg. Med. Chem. Lett., 2019.
[http://dx.doi.org/10.1016/j.bmcl.2019.06.013]
[http://dx.doi.org/10.1016/j.bmcl.2019.06.013]
[3]
He, X.X.; Chang, Y.; Meng, F.Y.; Wang, M.Y.; Xie, Q.H.; Tang, F.; Li, P.Y.; Song, Y.H.; Lin, J.S. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene, 2012, 31(28), 3357-3369.
[http://dx.doi.org//10.1038/onc.2011.500] [PMID: 22056881]
[http://dx.doi.org//10.1038/onc.2011.500] [PMID: 22056881]
[4]
Shi, C.; Yang, Y.; Xia, Y.; Okugawa, Y.; Yang, J.; Liang, Y.; Chen, H.; Zhang, P.; Wang, F.; Han, H.; Wu, W. Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer. Gut, 2016, 65(9), 1470-1481.
[http://dx.doi.org/10.1136/gutjnl-2014-308455] [PMID: 25994220]
[http://dx.doi.org/10.1136/gutjnl-2014-308455] [PMID: 25994220]
[5]
Mima, K.; Nishihara, R.; Yang, J.; Dou, R.; Masugi, Y.; Shi, Y.; Da Silva, A.; Cao, Y.; Song, M.; Nowak, J.; Gu, M. MicroRNA MIR21 (miR-21) and PTGS2 expression in colorectal cancer and patient survival. Clin. Cancer Res., 2016, 22(15), 3841-3848.
[http://dx.doi.org// 10.1158/1078-0432.CCR-15-2173] [PMID: 26957558]
[http://dx.doi.org// 10.1158/1078-0432.CCR-15-2173] [PMID: 26957558]
[6]
Jothimani, G.; Sriramulu, S.; Chabria, Y.; Sun, X.F.; Banerjee, A.; Pathak, S. A review on theragnostic applications of microRNAs and long non-coding RNAs in colorectal cancer. Curr. Top. Med. Chem., 2018, 19(30)
[http://dx.doi.org//10.2174/1568026619666181221165344]
[http://dx.doi.org//10.2174/1568026619666181221165344]
Article Metrics
![Wayfinder Image](/images/wayfinder.jpg)